NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that its first quarter revenues rose 12 percent year over year.

For the three months ended March 31, the firm said total revenues rose to $431.7 million from $384.9 million in the first quarter of 2017, beating analysts' consensus estimate of $417.4 million.

Bruker's organic revenue was up 4 percent year over year, while the favorable effect from changes in foreign currency rates was 8 percent, and growth from acquisitions was 1 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.